Delayed Hemolysis With Parenteral Artesunate-Reference-Cited by-同舟云学术

Delayed Hemolysis With Parenteral Artesunate

Published:2022-12-13 Issue: Volume: Page:001857872211424
ISSN:0018-5787
Container-title:Hospital Pharmacy
language:en
Short-container-title:Hosp Pharm

Author:

Awuah Alfred¹^ORCID,Shah Punit Jitendra²^ORCID,Tariq Farheen²

Affiliation:

1. Houston Methodist Hospital, Houston, TX, USA

2. Houston Methodist Sugar Land Hospital, Sugar Land, TX, USA

Abstract

Artesunate is an effective and first-line therapy option in patients with severe malaria caused by Plasmodium species. Among adverse effects of the drug is a phenomenon of delayed hemolysis. This usually occurs at least 7 days after initiation of therapy, and is characterized by reductions in hemoglobin and haptoglobin and an increase in lactate dehydrogenase. Here, we report an instance of delayed hemolysis in a patient probably attributed to parenteral artesunate therapy.

Publisher

SAGE Publications

Subject

Pharmacology (medical),Pharmacology,Pharmacy

Link

http://journals.sagepub.com/doi/pdf/10.1177/00185787221142471

Reference14 articles.

1. Artesunate [prescribing information]. Amivas LLC; 2020.

2. Delayed haemolysis after artesunate treatment of severe malaria – Review of the literature and perspective

3. Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins

4. Case definition: postartemisinin delayed hemolysis

5. Delayed Hemolysis After Treatment With Parenteral Artesunate in African Children With Severe Malaria—A Double-center Prospective Study

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artemether/lumefantrine/artesunate/atovaquone/proguanil;Reactions Weekly;2024-08-17